ITGA4 and lymphoma: Another anti-ITGA4 antibody (natalizumab) is already used in clinical settings for the treatment of autoimmune diseases such as multiple sclerosis32; however, its therapeutic effect on malignant lymphoma and leukemia remains unknown.